Fever produced by intrahypothalamic pyrogen: effect of protein synthesis inhibition by anisomycin.
In the unrestrained cat, the inhibition of protein synthesis by anisomycin, given either subcutaneously (5.0--25.0 mg/kg) or directly into the anterior hypothalamic, preoptic area (1.0--25.0 micrograms) impaired the development of a bacterial fever. S. typhosa infused intravenously (1:10 dilution in 1 ml) or into AH/POA (1.0 microliter) evoked an intense fever which was either significantly delayed or prevented by anisomycin. Conversely, anisomycin failed to affect the typical hyperthermia evoked by 100 ng PGE2 or 1.0--7.0 micrograms 5-HT similarly infused into AH/POA. These data demonstrate that an intermediary humoral factor of unknown nature is required in the hyperthermic effector pathway underlying the febrile response.
D000818:Animals; D000841:Anisomycin / Q000494:pharmacology*; D001831:Body Temperature / Q000187:drug effects; D002415:Cats; D004731:Endotoxins / Q000494:pharmacology*; D005260:Female; D005334:Fever / Q000139:chemically induced*; D007031:Hypothalamus / Q000187:drug effects*; D008297:Male; D009419:Nerve Tissue Proteins / Q000037:antagonists & inhibitors*; D011301:Preoptic Area / Q000187:drug effects; D011458:Prostaglandins E / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology*; D012485:Salmonella typhi; D012701:Serotonin / Q000494:pharmacology
D004731:Endotoxins; D009419:Nerve Tissue Proteins; D011458:Prostaglandins E; D011759:Pyrrolidines; D012701:Serotonin; D000841:Anisomycin